ES2164634T3 - Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto. - Google Patents

Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto.

Info

Publication number
ES2164634T3
ES2164634T3 ES90916421T ES90916421T ES2164634T3 ES 2164634 T3 ES2164634 T3 ES 2164634T3 ES 90916421 T ES90916421 T ES 90916421T ES 90916421 T ES90916421 T ES 90916421T ES 2164634 T3 ES2164634 T3 ES 2164634T3
Authority
ES
Spain
Prior art keywords
human
protein
production
effect
antibodies intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90916421T
Other languages
English (en)
Inventor
Charles R King
Patricia S Steeg
Lance A Liotta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of ES2164634T3 publication Critical patent/ES2164634T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

SE PRESENTAN EL ADN Y LA PROTEINA NM23 HUMANA ASI COMO LOS ANTICUERPOS QUE RECONOCEN LA PROTEINA NM23 HUMANA. EL ADN Y LOS ANTICUERPOS SE PUEDEN UTILIZAR PARA DETECTAR LA NM23 EN TUMORES HUMANOS PARA PREDECIR EL POTENCIAL MALIGNO DE TALES TUMORES.
ES90916421T 1989-10-18 1990-10-17 Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto. Expired - Lifetime ES2164634T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42280189A 1989-10-18 1989-10-18

Publications (1)

Publication Number Publication Date
ES2164634T3 true ES2164634T3 (es) 2002-03-01

Family

ID=23676440

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90916421T Expired - Lifetime ES2164634T3 (es) 1989-10-18 1990-10-17 Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto.

Country Status (10)

Country Link
US (3) US6423836B1 (es)
EP (1) EP0495910B1 (es)
JP (2) JP2758500B2 (es)
AT (1) ATE206129T1 (es)
AU (1) AU643971B2 (es)
CA (1) CA2067797C (es)
DE (1) DE69033810T2 (es)
DK (1) DK0495910T3 (es)
ES (1) ES2164634T3 (es)
WO (1) WO1991005793A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770386A (en) * 1992-05-20 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for increasing the sensitivity of a cell to a DNA damaging agent
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
AU6947298A (en) * 1997-04-03 1998-10-22 Joslin Diabetes Center Inc. Modulating the rad-nm23 interaction
WO2002094376A2 (en) * 2001-05-22 2002-11-28 Duke University Compositions and methods for promoting or inhibiting ndpk
GB0124145D0 (en) * 2001-10-08 2001-11-28 Bayer Ag Genes and proteins for prevention,prediction,prognosis and therapy of cardiovascular disease
TWI281473B (en) * 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
CN101918556B (zh) 2007-09-04 2013-06-12 株式会社普罗赛尔制药 可穿透细胞的nm23重组蛋白、编码其的多核苷酸以及包含其的抗转移组合物
JP2014517690A (ja) * 2011-05-09 2014-07-24 ミネルバ バイオテクノロジーズ コーポレーション 遺伝子操作した成長因子変異体

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35097A (en) * 1862-04-29 Improvement in machines for upsetting tires
US4808528A (en) * 1983-05-19 1989-02-28 Karl Tryggvason Antibody composition for the detection of malignant cells with metastatic cell activity
US4677058A (en) * 1983-05-19 1987-06-30 Karl Tryggvason Detecting malignant cells with monoclonal antibodies specific to type IV collagenase enzyme
US4816400A (en) * 1983-05-19 1989-03-28 Karl Tryggvason Basement membrane collagen degrading enzyme and method of purifying same
US5288852A (en) * 1984-03-06 1994-02-22 Dainippon Pharmaceutical Co., Ltd. Human tumor necrosis factor polypeptides
AU5197986A (en) * 1984-11-30 1986-06-18 Whitehead Institute For Biomedical Research Transmissible, mammalian genes associated with tumor metastasis
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
JPH01137994A (ja) * 1987-08-10 1989-05-30 Shionogi & Co Ltd ｒｅｇ蛋白質
US5049662A (en) 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
JPH01156999A (ja) * 1988-09-03 1989-06-20 Dainippon Pharmaceut Co Ltd ヒト癌壊死因子
WO1991006671A1 (fr) * 1989-10-31 1991-05-16 Institut Pasteur Moyens pour la detection de cellules hautement proliferatives
FR2653781B1 (fr) * 1989-10-31 1992-02-07 Pasteur Institut Procede de synthese de derives d'adenosine phosphate et derives obtenus.
US5874285A (en) * 1996-09-13 1999-02-23 Incyte Pharmaceuticals, Inc. Polynucleotide encoding a novel human nm23-like protein

Also Published As

Publication number Publication date
EP0495910A1 (en) 1992-07-29
DK0495910T3 (da) 2002-01-14
JPH04506457A (ja) 1992-11-12
JP3295358B2 (ja) 2002-06-24
JP2758500B2 (ja) 1998-05-28
CA2067797C (en) 1997-03-04
WO1991005793A1 (en) 1991-05-02
CA2067797A1 (en) 1991-04-19
EP0495910A4 (en) 1993-09-15
EP0495910B1 (en) 2001-09-26
DE69033810D1 (de) 2001-10-31
DE69033810T2 (de) 2002-03-28
US6087117A (en) 2000-07-11
AU643971B2 (en) 1993-12-02
JPH10212299A (ja) 1998-08-11
US6423836B1 (en) 2002-07-23
ATE206129T1 (de) 2001-10-15
US6329198B1 (en) 2001-12-11
AU7042491A (en) 1991-05-16

Similar Documents

Publication Publication Date Title
IT8149004A0 (it) Procedimento per determinare glicolegame associato a tumore nella diagnosi di cancro
SG46455A1 (en) Intraoperative and endoscopic tumor detection and therapy
DE69029206T2 (de) Verbesserte kapazitive Sonde
IT8748160A0 (it) Uso di bromocriptina nelle affezioni auto-immuni
BR8903920A (pt) Lingueta de tracionamento de cursor
ES2164634T3 (es) Produccion y uso de proteina nm23-h2 humana y anticuerpos previstos a tal efecto.
ES2071833T3 (es) Agente para neutralizar la actividad procoagulante asociada a celulas tumorales.
IT8223892A0 (it) Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle.
IE900141L (en) Acyl-peptide hydrolase and methods of production and use
IT8719292A0 (it) Composizione di anticorpi monoclonali umani cross-protettivi.
SE9500030D0 (sv) Method of determining metastatic potential of tumor cells
FR2442852A1 (fr) Nouvelles penicillines et leur application en therapeutique
IT8522688V0 (it) Iniziatore in prossimita' ad ultrasuoni.
FR2353282A1 (fr) Application de l'elastine et de ses derives en cosmetique
IT8583302A0 (it) Sintesi anidra in alta pressione della melammina.
FI942422A (fi) Menetelmä fysostigmiinin valmistuksessa käytettyjen välituotteiden enantioselektiivistä synteesiä varten
DK480885D0 (da) Antigene peptidforbindelser
ATE154098T1 (de) Verwendung kohlenwasserstoffreicher gele als fracturing-flüssigkeiten
BR9911294A (pt) Composição para o tratamento de imuno deficiências e métodos para sua preparação e uso
DE69001474D1 (de) Massnahmen zur verbesserung von seismischen prospektionsverfahren.
FR2670355B3 (fr) Pointe de soc de charrue en carbure.
SE8603524D0 (sv) Mjuk rorforbindelse mellan kroppens ytteryta och kavitet i dess inre- urholkad cancertumor
KR910011747U (ko) 중형지하출입문
LT2282B (lt) Ultragarsinis debito matavimo budas
SE9402150D0 (sv) Methods and means to obtain streptococcal proteins and the use of the genes encoding these proteins

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 495910

Country of ref document: ES